1. Home
  2. LAW vs TSHA Comparison

LAW vs TSHA Comparison

Compare LAW & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAW
  • TSHA
  • Stock Information
  • Founded
  • LAW 2013
  • TSHA 2019
  • Country
  • LAW United States
  • TSHA United States
  • Employees
  • LAW N/A
  • TSHA N/A
  • Industry
  • LAW Computer Software: Prepackaged Software
  • TSHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LAW Technology
  • TSHA Health Care
  • Exchange
  • LAW Nasdaq
  • TSHA Nasdaq
  • Market Cap
  • LAW 306.1M
  • TSHA 334.1M
  • IPO Year
  • LAW 2021
  • TSHA 2020
  • Fundamental
  • Price
  • LAW $4.47
  • TSHA $1.79
  • Analyst Decision
  • LAW Hold
  • TSHA Strong Buy
  • Analyst Count
  • LAW 4
  • TSHA 8
  • Target Price
  • LAW $6.88
  • TSHA $6.63
  • AVG Volume (30 Days)
  • LAW 157.7K
  • TSHA 1.6M
  • Earning Date
  • LAW 05-08-2025
  • TSHA 02-26-2025
  • Dividend Yield
  • LAW N/A
  • TSHA N/A
  • EPS Growth
  • LAW N/A
  • TSHA N/A
  • EPS
  • LAW N/A
  • TSHA N/A
  • Revenue
  • LAW $144,841,000.00
  • TSHA $8,333,000.00
  • Revenue This Year
  • LAW $5.43
  • TSHA N/A
  • Revenue Next Year
  • LAW $5.64
  • TSHA N/A
  • P/E Ratio
  • LAW N/A
  • TSHA N/A
  • Revenue Growth
  • LAW 4.89
  • TSHA N/A
  • 52 Week Low
  • LAW $4.19
  • TSHA $1.19
  • 52 Week High
  • LAW $8.57
  • TSHA $4.32
  • Technical
  • Relative Strength Index (RSI)
  • LAW 40.08
  • TSHA 60.47
  • Support Level
  • LAW $4.20
  • TSHA $1.69
  • Resistance Level
  • LAW $4.46
  • TSHA $1.79
  • Average True Range (ATR)
  • LAW 0.19
  • TSHA 0.11
  • MACD
  • LAW -0.04
  • TSHA 0.01
  • Stochastic Oscillator
  • LAW 27.35
  • TSHA 69.84

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

Share on Social Networks: